Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
Open Access
- 17 October 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 95 (8), 1108-1113
- https://doi.org/10.1038/sj.bjc.6603392
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreasCarcinogenesis: Integrative Cancer Research, 2006
- Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemiaLeukemia, 2003
- Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cellsBlood, 2003
- BRCA1 methylation: a significant role in tumour development?Seminars in Cancer Biology, 2002
- Cancer Susceptibility and the Functions of BRCA1 and BRCA2Cell, 2002
- A gene hypermethylation profile of human cancer.2001
- Expression of DNA methyltransferases DNMT1,3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemiaBlood, 2001
- Gene-Expression Profiles in Hereditary Breast CancerNew England Journal of Medicine, 2001
- Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian TumorsJNCI Journal of the National Cancer Institute, 2000
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000